1. Home
  2. SCLX vs MASS Comparison

SCLX vs MASS Comparison

Compare SCLX & MASS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • SCLX
  • MASS
  • Stock Information
  • Founded
  • SCLX 2011
  • MASS 2012
  • Country
  • SCLX United States
  • MASS United States
  • Employees
  • SCLX N/A
  • MASS N/A
  • Industry
  • SCLX Biotechnology: Pharmaceutical Preparations
  • MASS Medical/Dental Instruments
  • Sector
  • SCLX Health Care
  • MASS Health Care
  • Exchange
  • SCLX Nasdaq
  • MASS Nasdaq
  • Market Cap
  • SCLX 81.7M
  • MASS 77.0M
  • IPO Year
  • SCLX N/A
  • MASS 2020
  • Fundamental
  • Price
  • SCLX $0.48
  • MASS $1.97
  • Analyst Decision
  • SCLX Strong Buy
  • MASS Buy
  • Analyst Count
  • SCLX 3
  • MASS 3
  • Target Price
  • SCLX $11.33
  • MASS $8.00
  • AVG Volume (30 Days)
  • SCLX 184.3K
  • MASS 252.2K
  • Earning Date
  • SCLX 12-24-2024
  • MASS 11-12-2024
  • Dividend Yield
  • SCLX N/A
  • MASS N/A
  • EPS Growth
  • SCLX N/A
  • MASS N/A
  • EPS
  • SCLX N/A
  • MASS N/A
  • Revenue
  • SCLX $50,833,000.00
  • MASS $55,162,000.00
  • Revenue This Year
  • SCLX $32.77
  • MASS $15.31
  • Revenue Next Year
  • SCLX $50.71
  • MASS $16.10
  • P/E Ratio
  • SCLX N/A
  • MASS N/A
  • Revenue Growth
  • SCLX 9.41
  • MASS 16.08
  • 52 Week Low
  • SCLX $0.46
  • MASS $2.00
  • 52 Week High
  • SCLX $2.63
  • MASS $12.51
  • Technical
  • Relative Strength Index (RSI)
  • SCLX 33.34
  • MASS 34.25
  • Support Level
  • SCLX $0.48
  • MASS $2.01
  • Resistance Level
  • SCLX $0.54
  • MASS $2.32
  • Average True Range (ATR)
  • SCLX 0.06
  • MASS 0.17
  • MACD
  • SCLX -0.00
  • MASS -0.02
  • Stochastic Oscillator
  • SCLX 4.53
  • MASS 5.76

About SCLX Scilex Holding Company

Scilex Holding Co is focused on acquiring, developing, and commercializing non-opioid pain management products for the treatment of acute and chronic pain. The Company's commercial product, ZTlido (lidocaine topical system), is a prescription lidocaine topical product for the relief of pain associated with postherpetic neuralgia, which is a form of post-shingles nerve pain. It is focused on commercializing Gloperba (colchicine USP) an oral solution, a prophylactic treatment for painful gout flares in adults. The Company's three product candidates are SP-102 or SEMDEXA viscous gel formulation of a used corticosteroid for epidural injections, SP-103 a Phase 2, triple-strength formulation of ZTlido, and SP-104, 4.5 mg Delayed Burst Release Low Dose Naltrexone Hydrochloride (DBR-LDN) Capsule.

About MASS 908 Devices Inc.

908 Devices Inc manufactures medical devices. It has developed a suite of purpose-built handheld and desktop mass spectrometry, or Mass Spec, devices for the point-of-need. Mass Spec devices are used at the point-of-need to interrogate unknown and invisible materials and provide quick, actionable answers to directly address some of the critical problems in life sciences research, bioprocessing, industrial biotech, forensics, and adjacent markets. The company geographically derives maximum revenue from United States, and also has its presence in Europe, Middle East and Africa, Americas and Other and Asia Pacific.

Share on Social Networks: